Skip to main content

Frost Phillip MD Et Al's Form 4 filing

Opko Health, Inc. (OPK) · filed Oct 28, 2022

Accession no.
0001209191-22-054748
Filed
Oct 28, 2022, 6:49 AM ET
Trade date
Oct 27, 2022
Filing delay
1 day
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 10 non-derivative transactions. Open-market purchases total $182.0K. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Frost Phillip MD Et AlCIK 0000898860Director, Officer (CEO & Chairman), 10% Owner
Frost Gamma Investments TrustCIK 000138089610% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Oct 27, 2022Common StockPPurchaseAcquired+600$1.80+$1,081.5198,232,294Indirect
Oct 27, 2022Common StockPPurchaseAcquired+30,723$1.81+$55,455.02198,263,017Indirect
Oct 27, 2022Common StockPPurchaseAcquired+190$1.81+$343.9198,263,207Indirect
Oct 27, 2022Common StockPPurchaseAcquired+925$1.82+$1,678.88198,264,132Indirect
Oct 27, 2022Common StockPPurchaseAcquired+200$1.82+$363.8198,264,332Indirect
Oct 27, 2022Common StockPPurchaseAcquired+23,875$1.82+$43,452.5198,288,207Indirect
Oct 27, 2022Common StockPPurchaseAcquired+3,600$1.83+$6,570198,291,807Indirect
Oct 27, 2022Common StockPPurchaseAcquired+4,900$1.83+$8,962.1198,296,707Indirect
Oct 27, 2022Common StockPPurchaseAcquired+20,600$1.83+$37,698198,317,307Indirect
Oct 27, 2022Common StockPPurchaseAcquired+14,387$1.84+$26,400.15198,331,694Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)